Company Overview and News

 
Global Gearboxes and Gear Motors Market Propelled by Preference for Energy-efficient Systems

2017-09-13 prnewswire
Successful companies will be those that focus on vibrant market segments and direct drive systems, finds Frost & Sullivan's Mechanical Power Transmission team

 
The U.S. Is No Longer Center Of The Universe. Where To Invest?

2017-08-11 seekingalpha
Norwegian Sovereign Fund objects to weighting of companies with low % of voting shares, in indices.

 
Xylem's Robust Water Treatment Services to Boost Growth

2016-05-05 zacks
On May 4, 2016, we issued an updated research report on premium diversified machinery company, Xylem Inc. (XYL - Analyst Report). The company provides non-imitable engineering services that are widely used in different types of wastewater and water applications. Since its inception, Xylem has successfully expanded the scale of its business across international markets like the Asia Pacific, Europe and the U.

 
Gear Motors Market by Product, by Gear Type, by Rated Power, by Torque, by Industry & by Region - Global Trends & Forecast to 2021

2016-04-26 prnewswire
"The gear motors market is projected to grow at a CAGR of 5.8% from 2016 to 2021"

 
Gear Motors Market Worth 23.94 Billion USD by 2021

2016-04-04 prnewswire
The report "Gear Motors Market by Product (Gearbox & Gear Motor), by Gear Type (Helical, Planetary, Helical-Bevel, Worm, & Others), by Rated Power, by Torque (Up to 10,000 Nm, Above 10,000 Nm), by Industry & by Region - Global Trends & Forecast to 2021", published by MarketsandMarkets, The market is projected to grow from an estimated USD 18.08 Billion in 2016 to USD 23.94 Billion by 2021, registering a CAGR of 5.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

8h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

8h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

18h - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...